Notice of Change to PA-17-239 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)"

Notice Number: NOT-CA-17-046

Key Dates
Release Date:   April 7, 2017

Related Announcements
PA-17-239

Issued by
National Cancer Institute (NCI)
National Human Genome Research Institute (NHGRI)
National Institute on Dental and Craniofacial Research (NIDCR)

Purpose

The purpose of this Notice is to add to PA-17-239 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)".
The following "Data sharing" subsection (in italics) has been added, before the "Collaborations and authorship" subsection.

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description
Currently reads

Collaborations and authorship
Projects developed in response to this FOA should include expertise such as cancer epidemiology, omics, biostatistics, bioinformatics, and/or computational biology.
Any publications resulting from awards funded under this FOA must include acknowledgment of the source of shared data and any funding sources which supported the initial data collection.
Applicant should discuss co-authorship plans with original and/or contributing investigator(s) prior to submitting an application.

 

Modified to read
Data sharing

Applicants are encouraged to make publicly available the cleaned and harmonized datasets, software and programmed codes developed for the secondary analysis and integration of the data, when appropriate, and consistent with participant informed consent. Sharing of adequate documentation and explanation is also encouraged so that data and tools can be used by researchers not associated with the original study.

Collaborations and authorship
Projects developed in response to this FOA should include expertise such as cancer epidemiology, omics, biostatistics, bioinformatics, and/or computational biology.
Any publications resulting from awards funded under this FOA must include acknowledgment of the source of shared data and any funding sources which supported the initial data collection.
Applicant should discuss co-authorship plans with original and/or contributing investigator(s) prior to submitting an application.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Melissa Rotunno, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7245 
Email: rotunnom@mail.nih.gov